Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

Cited by (1,002)

Items 101–200 of 1,002

1. A status report on RNAi therapeutics
   Akshay K. Vaishnaw, Jared Gollob, Christina Gamba‐Vitalo, Renta M. Hutabarat, Dinah W.Y. Sah, Rachel E. Meyers, Tony de Fougerolles, John M. Maraganore · 2010 · Silence
2. Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine
   Jiayu Ren, Nicholas Andrikopoulos, Kelly Velonia, Huayuan Tang, Rong Cai, Feng Ding, Pu Chun Ke, Chunying Chen · 2022 · Journal of the American Chemical Society
3. Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
   Brown, Christopher R, Gupta, Swati, Qin, June, Racie, Timothy, He, Guo, Lentini, Scott, Malone, Ryan, Yu, Mikyung, Matsuda, Shigeo, Shulga-Morskaya, Svetlana et al. · 2020 · Nucleic Acids Research
4. mRNA-based therapeutics: looking beyond COVID-19 vaccines
   Hamideh Parhiz, Elena N. Atochina‐Vasserman, Drew Weissman · 2024 · The Lancet
5. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
   Jung, Han Na, Lee, Seok-Yong, Lee, Somin, Youn, Hyewon, Im, Hyung-Jun · 2022 · Theranostics
6. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
   Samuel T. LoPresti, Mariah Lynn Arral, Namit Chaudhary, Kathryn A. Whitehead · 2022 · Journal of Controlled Release
7. Synthetic biology in mammalian cells: next generation research tools and therapeutics
   Florian Lienert, Jason J. Lohmueller, Abhishek Dinkarnath Garg, Pamela A. Silver · 2014 · Nature Reviews Molecular Cell Biology
8. Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
   Rosemary L. Kanasty, Kathryn A. Whitehead, Arturo J. Vegas, Daniel G. Anderson · 2012 · Molecular Therapy
9. Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation
   Jeonghwan Kim, Antony Jozić, Yuxin Lin, Yulia Eygeris, Elissa Bloom, Xiaochen Tan, Christopher Acosta, Kelvin D. MacDonald, Kevin Welsher, Gaurav Sahay · 2022 · ACS Nano
10. Engineering and physical sciences in oncology: challenges and opportunities
    Mitchell, Michael J., Jain, Rakesh K., Langer, Robert · 2017 · Nature Reviews Cancer
11. Lipid-based nanoparticle technologies for liver targeting
    Roland Böttger, Griffin Pauli, Po‐Han Chao, Nojoud AL Fayez, Lukas Hohenwarter, Shyh‐Dar Li · 2020 · Advanced Drug Delivery Reviews
12. A Review on Electroporation-Based Intracellular Delivery
    Junfeng Shi, Yifan Ma, Jing Zhu, Yuanxin Chen, Yating Sun, Yicheng Yao, Zhaogang Yang, Jing Xie · 2018 · Molecules
13. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
    Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, Adam K. Wheatley, Danijela Zukancic, Azizah Algarni, Hareth A. Al-Wassiti, Thomas Paul Davis, Colin William Pouton, Stephen John Kent et al. · 2021 · Acta Biomaterialia
14. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver
    Rui Zhang, Rakan D. El-Mayta, Timothy J. Murdoch, Claude C. Warzecha, Margaret M. Billingsley, Sarah J. Shepherd, Ningqiang Gong, Lili Wang, James M. Wilson, Daeyeon Lee et al. · 2020 · Biomaterials Science
15. Lipid nanoparticles for delivery of messenger RNA to the back of the eye
    Patel, Siddharth, Ryals, Renee C., Weller, Kyle K., Pennesi, Mark E., Sahay, Gaurav · 2019 · Journal of Controlled Release
16. The effects of protein corona on in vivo fate of nanocarriers
    Qingqing Xiao, Makhloufi Zoulikha, Min Qiu, Chao Teng, Chenshi Lin, Xiaotong Li, Marwa A. Sallam, Qiaobing Xu, Wei He · 2022 · Advanced Drug Delivery Reviews
17. Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
    Hannah J. Vaughan, Jordan J. Green, Stephany Y. Tzeng · 2019 · Advanced Materials
18. Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
    Seyed Hossein Kiaie, Naime Majidi Zolbanin, Armin Ahmadi, Rafieh Bagherifar, Hadi Valizadeh, Fatah Kashanchi, Reza Jafari · 2022 · Journal of Nanobiotechnology
19. Lipid-Based Nanoparticles for siRNA Delivery in Cancer Therapy: Paradigms and Challenges
    Lígia Catarina Gomes-da-Silva, Nuno André Fonseca, Vera Moura, Maria C. Pedroso de Lima, Sérgio Simões, João Nuno Moreira · 2012 · Accounts of Chemical Research
20. Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA
    Patel, Siddharth, Ashwanikumar, N., Robinson, Emily, DuRoss, Allison, Sun, Conroy, Murphy-Benenato, Kerry E., Mihai, Cosmin, Almarsson, Örn, Sahay, Gaurav · 2017 · Nano Letters
21. Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
    Jialiang Wang, Yaopeng Ding, K. Chul Chong, Meng Cui, Zeyu Cao, Chenjue Tang, Zhen Tian, Yuping Hu, Yu Zhao, Shaoyi Jiang · 2024 · Vaccines
22. Bifunctional small molecules that mediate the degradation of extracellular proteins
    Caianiello, David F., Zhang, Mengwen, Ray, Jason D., Howell, Rebecca A., Swartzel, Jake C., Branham, Emily M. J., Chirkin, Egor, Sabbasani, Venkata R., Gong, Angela Z., McDonald, David M. et al. · 2021 · Nature Chemical Biology
23. Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
    Basmah Nasser Aldosari, Iman Mohammed Alfagih, Alanood S. Almurshedi · 2021 · Pharmaceutics
24. Long-term storage of lipid-like nanoparticles for mRNA delivery
    Zhao, Pengxuan, Hou, Xucheng, Yan, Jingyue, Du, Shi, Xue, Yonger, Li, Wenqing, Xiang, Guangya, Dong, Yizhou · 2020 · Bioactive Materials
25. Nanoparticle-Mediated Systemic Delivery of siRNA for Treatment of Cancers and Viral Infections
    Mohamed Shehata Draz, Binbin Amanda Fang, Pengfei Zhang, Zhi Hu, Shenda Gu, Kevin C. Weng, Joe W. Gray, Fanqing Frank Chen · 2014 · Theranostics
26. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
    Parhiz, Hamideh, Shuvaev, Vladimir V., Pardi, Norbert, Khoshnejad, Makan, Kiseleva, Raisa Yu, Brenner, Jacob S., Uhler, Thomas, Tuyishime, Steven, Mui, Barbara L., Tam, Ying K. et al. · 2018 · Journal of Controlled Release
27. Advances in lipid nanoparticles for siRNA delivery
    Tam, Yuen, Chen, Sam, Cullis, Pieter · 2013 · Pharmaceutics
28. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA
    Jayesh A. Kulkarni, J. Layne Myhre, Sam Chen, Yuen Yi C. Tam, Adrian Danescu, Joy Marion Richman, Pieter R. Cullis · 2016 · Nanomedicine Nanotechnology Biology and Medicine
29. Strategies to reduce the risks of mRNA drug and vaccine toxicity
    Dimitrios Bitounis, Eric Jacquinet, Maximillian A. Rogers, Mansoor M. Amiji · 2024 · Nature Reviews Drug Discovery
30. Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
    Chong Qiu, Fei Xia, Junzhe Zhang, Qiaoli Shi, Yuqing Meng, Chen Wang, Huanhuan Pang, Liwei Gu, Chengchao Xu, Qiuyan Guo et al. · 2023 · Research
31. Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale
    Prasath Paramasivam, Christian Franke, Martin Stöter, Andreas Höijer, Stefano Bartesaghi, Alan Sabirsh, Lennart Lindfors, Marianna Yanez Arteta, Anders Dahlén, Annette Bak et al. · 2021 · The Journal of Cell Biology
32. Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy
    Varun Kumar, June Qin, Yongfeng Jiang, Richard G. Duncan, Benjamin Brigham, Shannon Fishman, Jayaprakash K. Nair, Akin Akinc, Scott A. Barros, Pia V. Kasperkovitz · 2014 · Molecular Therapy — Nucleic Acids
33. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening
    Pedro Pires Goulart Guimarães, Rui Zhang, Roman Spektor, Mingchee Tan, Amanda Chung, Margaret M. Billingsley, Rakan D. El-Mayta, Rachel Riley, Lili Wang, James M. Wilson et al. · 2019 · Journal of Controlled Release
34. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
    Michaela Jeong, Yeji Lee, Jeongeun Park, Hyein Jung, Hyukjin Lee · 2023 · Advanced Drug Delivery Reviews
35. Delivery systems for siRNA drug development in cancer therapy
    Cong‐Fei Xu, Jun Wang · 2014 · Asian Journal of Pharmaceutical Sciences
36. Paving the Road for RNA Therapeutics
    Niels Dammes, Dan Peer · 2020 · Trends in Pharmacological Sciences
37. Current issues of RNAi therapeutics delivery and development
    Dirk Haussecker · 2014 · Journal of Controlled Release
38. Progress Toward In Vivo Use of siRNAs-II
    Garrett R. Rettig, Mark A. Behlke · 2011 · Molecular Therapy
39. Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate
    Tracy S. Zimmermann, Verena Karsten, Amy Chan, Joseph Chiesa, Malcolm J. Boyce, Brian R. Bettencourt, Renta M. Hutabarat, Saraswathy V. Nochur, Akshay K. Vaishnaw, Jared Gollob · 2017 · Molecular Therapy
40. Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin‐Mediated Amyloidosis
    Xiaoping Zhang, Varun Goel, Gabriel J. Robbie · 2019 · The Journal of Clinical Pharmacology
41. Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
    Jilian R. Melamed, Saigopalakrishna S. Yerneni, Mariah Lynn Arral, Samuel T. LoPresti, Namit Chaudhary, Anuradha Sehrawat, Hiromi Muramatsu, Mohamad‐Gabriel Alameh, Norbert Pardi, Drew Weissman et al. · 2023 · Science Advances
42. Exploiting Endocytosis for Nanomedicines
    Akin Akinc, Giuseppe Battaglia · 2013 · Cold Spring Harbor Perspectives in Biology
43. A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
    Srinivas Ramishetti, Inbal Hazan‐Halevy, Ramesh Palakuri, Sushmita Chatterjee, Gonna Somu Naidu, Niels Dammes, Inbar Freilich, Luba Kolik Shmuel, Dganit Danino, Dan Peer · 2020 · Advanced Materials
44. RNA interference in the era of nucleic acid therapeutics
    Vasant Jadhav, Akshay K. Vaishnaw, Kevin J. Fitzgerald, Martin A. Maier · 2024 · Nature Biotechnology
45. Targeting and engineering long non-coding RNAs for cancer therapy
    Michela Coan, Simon Haefliger, Samir Ounzain, Rory Johnson · 2024 · Nature Reviews Genetics
46. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe−/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia
    Schmidt, Paul J., Toudjarska, Iva, Sendamarai, Anoop K., Racie, Tim, Milstein, Stuart, Bettencourt, Brian R., Hettinger, Julia, Bumcrot, David, Fleming, Mark D. · 2013 · Blood
47. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
    Abigail Liebow, Xingsheng Li, Timothy Racie, Julia L. Hettinger, Brian R. Bettencourt, Nader Najafian, Patrick A. J. Haslett, Kevin J. Fitzgerald, Ross P. Holmes, David V. Erbe et al. · 2016 · Journal of the American Society of Nephrology
48. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
    Xuexiang Han, Ningqiang Gong, Lulu Xue, Margaret M. Billingsley, Rakan D. El-Mayta, Sarah J. Shepherd, Mohamad‐Gabriel Alameh, Drew Weissman, Michael J. Mitchell · 2023 · Nature Communications
49. Next-Generation Lipids in RNA Interference Therapeutics
    Stephanie Rietwyk, Dan Peer · 2017 · ACS Nano
50. Imaging small molecule-induced endosomal escape of siRNA
    Hampus Du Rietz, Hampus Hedlund, Sten Wilhelmson, Pontus Nordenfelt, Anders Wittrup · 2020 · Nature Communications
51. The effects of PEGylation on LNP based mRNA delivery to the eye
    Ryals, Renee C., Patel, Siddharth, Acosta, Chris, McKinney, Madison, Pennesi, Mark E., Sahay, Gaurav · 2020 · PLOS ONE
52. Lipid nanoparticle delivery systems for siRNA-based therapeutics
    Chung Ping Leon Wan, Theresa M. Allen, Pieter R. Cullis · 2013 · Drug Delivery and Translational Research
53. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System
    Pattipeiluhu, Roy, Arias‐Alpizar, Gabriela, Basha, Genc, Chan, Karen Y. T., Bussmann, Jeroen, Sharp, Thomas H., Moradi, Mohammad‐Amin, Sommerdijk, Nico, Harris, Edward N., Cullis, Pieter R. et al. · 2022 · Advanced Materials
54. Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
    Huanzhen Ni, Marine Z. C. Hatit, Kun Zhao, David Loughrey, Melissa P. Lokugamage, Hannah E. Peck, Ada Del Cid, Abinaya Muralidharan, YongTae Kim, Philip J. Santangelo et al. · 2022 · Nature Communications
55. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier
    Lakmali Munasinghage Silva, Andrew D. Doyle, Teresa Greenwell‐Wild, Nicolás Dutzan, Collin L. Tran, Loreto Abusleme, Lih Jiin Juang, Jerry Leung, Elizabeth M. Chun, Andrew Gary Lum et al. · 2021 · Science
56. Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery
    Alabi, Christopher A., Love, Kevin T., Sahay, Gaurav, Yin, Hao, Luly, Kathryn M., Langer, Robert, Anderson, Daniel G. · 2013 · Proceedings of the National Academy of Sciences
57. Lipid nanoparticle-mediated drug delivery to the brain
    Khare, Purva, Edgecomb, Sara X., Hamadani, Christine M., Tanner, Eden E.L., S Manickam, Devika · 2023 · Advanced Drug Delivery Reviews
58. Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
    Jeremy Bost, Hanna M. G. Barriga, Margaret N. Holme, Audrey Gallud, Marco Maugeri, Dhanu Gupta, Taavi Lehto, Hadi Valadi, Elin K. Esbjörner, Molly M. Stevens et al. · 2021 · ACS Nano
59. In vivo editing of lung stem cells for durable gene correction in mice
    Yehui Sun, Sumanta Chatterjee, Xizhen Lian, Zachary Traylor, Sandhya Ramani Sattiraju, Yufen Xiao, Sean A. Dilliard, Yun‐Chieh Sung, Minjeong Kim, Sang M. Lee et al. · 2024 · Science
60. Delivery of oligonucleotides with lipid nanoparticles
    Yuhua Wang, Lei Miao, Andrew Satterlee, Leaf Huang · 2015 · Advanced Drug Delivery Reviews
61. Efficient nanocarriers of siRNA therapeutics for cancer treatment
    Md Abdus Subhan, Vladimir P. Torchilin · 2019 · Translational research
62. Clinical and immunological effects of mRNA vaccines in malignant diseases
    Annkristin Heine, Stefan Juranek, Peter Brossart · 2021 · Molecular Cancer
63. Smart Biomaterials: Recent Advances and Future Directions
    Piotr S. Kowalski, Chandrabali Bhattacharya, Samson Afewerki, Róbert Langer · 2018 · ACS Biomaterials Science & Engineering
64. Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells
    Genc Basha, Tatiana I. Novobrantseva, Nicole L. Rosin, Yuen Yi C. Tam, Ismail M. Hafez, Matthew Wong, Tsukasa Sugo, Vera M. Ruda, June Qin, Boris Klebanov et al. · 2011 · Molecular Therapy
65. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo
    Yusuke Sato, Kazuki Hashiba, Kosuke Sasaki, Masatoshi Maeki, Manabu Tokeshi, Hideyoshi Harashima · 2019 · Journal of Controlled Release
66. Recent Advances in Lipid Nanoparticles for Delivery of mRNA
    Lei Yang, Liming Gong, Ping Wang, Xinghui Zhao, Feng Hua Zhao, Zhijie Zhang, Yunfei Li, Wei Huang · 2022 · Pharmaceutics
67. Drug delivery systems for CRISPR-based genome editors
    Victoria J. Madigan, Feng Zhang, James E. Dahlman · 2023 · Nature Reviews Drug Discovery
68. In vivo delivery of RNAi with lipid-based nanoparticles
    Huang, Leaf, Liu, Yang · 2011 · Annual Review of Biomedical Engineering
69. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection
    Gustavo Lou, Giulia Anderluzzi, S. Schmidt, Stuart Woods, Simona Gallorini, Michela Brazzoli, Fabiola Giusti, Ilaria Ferlenghi, Russell N. Johnson, Craig W. Roberts et al. · 2020 · Journal of Controlled Release
70. Non-liver mRNA Delivery
    Loughrey, David, Dahlman, James E. · 2022 · Accounts of Chemical Research
71. Drug targeting to the diseased liver
    Poelstra, Klaas, Prakash, Jai, Beljaars, Leonie · 2012 · Journal of Controlled Release
72. GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy
    Lisa N. Kasiewicz, Souvik Biswas, Aaron Beach, Huilan Ren, Chaitali Dutta, Anne Marie Mazzola, Ellen Rohde, Alexandra C. Chadwick, Christopher Cheng, Sara P. Garcia et al. · 2023 · Nature Communications
73. Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain
    Rungta, Ravi L, Choi, Hyun B, Lin, Paulo JC, Ko, Rebecca WY, Ashby, Donovan, Nair, Jay, Manoharan, Muthiah, Cullis, Pieter R, MacVicar, Brian A · 2013 · Molecular Therapy—Nucleic Acids
74. Understanding Nanomaterial–Liver Interactions to Facilitate the Development of Safer Nanoapplications
    Jiulong Li, Chunying Chen, Tian Xia · 2022 · Advanced Materials
75. Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain
    Han, Emily L., Tang, Sophia, Kim, Dongyoon, Murray, Amanda M., Swingle, Kelsey L., Hamilton, Alex G., Mrksich, Kaitlin, Padilla, Marshall S., Palanki, Rohan, Li, Jacqueline J. et al. · 2025 · Nano Letters
76. Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside
    Zatsepin · 2016 · International Journal of Nanomedicine
77. Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
    Mohan Liu, Yusi Wang, Yi-Bing Zhang, Die Hu, Lin Tang, Bailing Zhou, Li Yang · 2025 · Signal Transduction and Targeted Therapy
78. Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery
    Paunovska, Kalina, Gil, Carmen J., Lokugamage, Melissa P., Sago, Cory D., Sato, Manaka, Lando, Gwyn N., Gamboa Castro, Marielena, Bryksin, Anton V., Dahlman, James E. · 2018 · ACS Nano
79. Lipid nanoparticles for short interfering RNA delivery
    Leung, Alex K.K., Tam, Yuen Yi C., Cullis, Pieter R. · 2014 · Advances in genetics
80. Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
    DeRosa, F, Guild, B, Karve, S, Smith, L, Love, K, Dorkin, J R, Kauffman, K J, Zhang, J, Yahalom, B, Anderson, D G et al. · 2016 · Gene Therapy
81. Clinical advances of siRNA therapeutics
    Bo Hu, Yuhua Weng, Xinhua Xia, Xing‐Jie Liang, Yuanyu Huang · 2019 · The Journal of Gene Medicine
82. Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands
    Melissa P. Lokugamage, Cory D. Sago, Zubao Gan, Brandon R. Krupczak, James E. Dahlman · 2019 · Advanced Materials
83. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
    Fatima Rizvi, Elissa Everton, Anna R. Smith, Hua Liu, Elizabeth Osota, Mitchell B. Beattie, Ying K. Tam, Norbert Pardi, Drew Weissman, Valerie Gouon–Evans · 2021 · Nature Communications
84. Recent Advances in Nanoparticle-Mediated siRNA Delivery
    John‐Michael Williford, Juan Wu, Yong Ren, Maani M. Archang, Kam W. Leong, Hai‐Quan Mao · 2014 · Annual Review of Biomedical Engineering
85. The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles
    Dongyu Chen, Shanthi Ganesh, Weimin Wang, Mansoor M. Amiji · 2019 · Nanoscale
86. A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery
    Michael J. Munson, Gwen O’Driscoll, Andreia Machado da Silva, Elisa Lázaro‐Ibáñez, Audrey Gallud, John T. Wilson, Anna Collén, Elin K. Esbjörner, Alan Sabirsh · 2021 · Communications Biology
87. Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans
    Cagigi, Alberto, Loré, Karin · 2021 · Vaccines
88. The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles
    Sean A. Dilliard, Yehui Sun, Madeline O. Brown, Yun‐Chieh Sung, Sumanta Chatterjee, Lukas Farbiak, Amogh Vaidya, Xizhen Lian, Xu Wang, Andrew S. Lemoff et al. · 2023 · Journal of Controlled Release
89. Delivery is key: lessons learnt from developing splice‐switching antisense therapies
    Caroline Godfrey, Lourdes R. Desviat, Bård H. Smedsrød, France Piétri‐Rouxel, Michela A. Denti, Petra Disterer, Stéphanie Lorain, Gisela Nogales‐Gadea, Valentina Sardone, Rayan Anwar et al. · 2017 · EMBO Molecular Medicine
90. Strategies for non-viral vectors targeting organs beyond the liver
    Jeonghwan Kim, Yulia Eygeris, Renee C. Ryals, Antony Jozić, Gaurav Sahay · 2023 · Nature Nanotechnology
91. Enhancing immunotherapy with tumour-responsive nanomaterials
    Stephen W. Linderman, Louis B. DeRidder, Lucía Sanjurjo, Michael Bonner Foote, Marı́a José Alonso, Ameya R. Kirtane, Róbert Langer, Giovanni Traverso · 2025 · Nature Reviews Clinical Oncology
92. Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
    Jayaraman, Muthusamy, Ansell, Steven M., Mui, Barbara L., Tam, Ying K., Chen, Jianxin, Du, Xinyao, Butler, David, Eltepu, Laxman, Matsuda, Shigeo, Narayanannair, Jayaprakash K. et al. · 2012 · Angewandte Chemie
93. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration
    Chen, Sam, Tam, Yuen Yi C., Lin, Paulo J.C., Leung, Alex K.K., Tam, Ying K., Cullis, Pieter R. · 2014 · Journal of Controlled Release
94. Oligonucleotide Conjugates for Therapeutic Applications
    Johannes Winkler · 2013 · Therapeutic Delivery
95. Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care
    Marco Luigetti, Ângela Romano, Andrea Di Paolantonio, Giulia Bisogni, Mario Sabatelli · 2020 · Therapeutics and Clinical Risk Management
96. Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles
    Marine Z. C. Hatit, Melissa P. Lokugamage, Curtis N. Dobrowolski, Kalina Paunovska, Huanzhen Ni, Kun Zhao, Daryll A. Vanover, Jared P. Beyersdorf, Hannah E. Peck, David Loughrey et al. · 2022 · Nature Nanotechnology
97. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells
    Francesca Ferraresso, Amy W. Strilchuk, Lih Jiin Juang, Lauren G. Poole, James P. Luyendyk, Christian J. Kastrup · 2022 · Molecular Pharmaceutics
98. Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain
    Ogawa, Koki, Kato, Naoya, Yoshida, Michiharu, Hiu, Takeshi, Matsuo, Takayuki, Mizukami, Shusaku, Omata, Daiki, Suzuki, Ryo, Maruyama, Kazuo, Mukai, Hidefumi et al. · 2022 · Journal of Controlled Release
99. Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay
    Hans J. Gaus, Ruchi Gupta, Alfred E. Chappell, Michael E. Østergaard, Eric E. Swayze, Punit P. Seth · 2018 · Nucleic Acids Research
100. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
     Lucía Barbier‐Torres, Karen A. Fortner, Paula Iruzubieta, Teresa C. Delgado, Emily L. Giddings, Youdinghuan Chen, Devin Champagne, David Fernández‐Ramos, Daniela Mestre, Beatriz Gómez‐Santos et al. · 2020 · Nature Communications